- Home
- Contractors
- Genentech USA, Inc
Genentech USA, Inc government contracts
$165M obligated across 4 federal awards. 1 is still running.
Who buys from Genentech USA, Inc
| Agency | Awards | Obligated |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | 4 | $165M |
What Genentech USA, Inc sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| Pharmaceutical Preparation Manufacturing NAICS 325412 | 4 | $165M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
| Award | Obligated | Start | End |
|---|---|---|---|
| PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS Office of Assistant Secretary for Preparedness and Response · 75A50325F80036 | $37.5M | Sep 26, 2025 | Sep 29, 2027 |
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
| Award | Obligated | Start | End |
|---|---|---|---|
| THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF STRATEGIC NATIONAL STOCKPILE (DSNS), ASSISTANT SECRETARY OF PREPAREDNESS AND RESPONSE (ASPR), WITH A CONTRACTING VEHICLE FOR PRODUCT(S) NEEDED IN ORDER TO SUPP Office of Assistant Secretary for Preparedness and Response · 75A50322F80028 | $60M | Sep 14, 2022 | Mar 31, 2025 |
| OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES Office of Assistant Secretary for Preparedness and Response · 75A50325F80003 | $45.1M | Jan 30, 2025 | Jun 6, 2025 |
| PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS Office of Assistant Secretary for Preparedness and Response · 75A50325F80036 | $37.5M | Sep 26, 2025 | Sep 29, 2027 |
| XOFLUZA (BALOXAVIR MARBOXIL) Office of Assistant Secretary for Preparedness and Response · 75A50324F80013 | $22M | Sep 30, 2024 | Sep 29, 2025 |
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| Mckesson Corporation UEI S1RUKWWRYFL6 | 237 | $32.9B |
| Sanofi Vaccines US Inc. UEI NCXBGGQ8YTU9 | 8 | $310M |
| Chartwell RX LLC UEI ER5UA9TYBGH4 | 3 | $260M |
| Dla Troop Support UEI JSJMNWTKEJN3 | 3 | $241M |
| Exelan Pharmaceuticals Inc UEI FYZXNHSQTMG8 | 42 | $174M |
| Fresenius Kabi, LLC UEI C2TRNWNQKMD6 | 3 | $124M |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Genentech USA, Inc's UEI?
SA85BMHCTXK5. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Genentech USA, Inc won in federal contracts?
$165M obligated across 4 awards in Captivaq's records, most of it from Office of Assistant Secretary for Preparedness and Response. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Genentech USA, Inc contracts end soon?
1 award ends in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.